AR032879A1 - Compuestos derivados de ecteinascidina, sus composiciones farmaceuticas, sus usos y metodo de tratamiento de tumores - Google Patents
Compuestos derivados de ecteinascidina, sus composiciones farmaceuticas, sus usos y metodo de tratamiento de tumoresInfo
- Publication number
- AR032879A1 AR032879A1 ARP010101773A ARP010101773A AR032879A1 AR 032879 A1 AR032879 A1 AR 032879A1 AR P010101773 A ARP010101773 A AR P010101773A AR P010101773 A ARP010101773 A AR P010101773A AR 032879 A1 AR032879 A1 AR 032879A1
- Authority
- AR
- Argentina
- Prior art keywords
- ecteinascidin
- pharmaceutical compositions
- compounds
- ecteinascidine
- rings
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- PKVRCIRHQMSYJX-AIFWHQITSA-N trabectedin Chemical compound C([C@@]1(C(OC2)=O)NCCC3=C1C=C(C(=C3)O)OC)S[C@@H]1C3=C(OC(C)=O)C(C)=C4OCOC4=C3[C@H]2N2[C@@H](O)[C@H](CC=3C4=C(O)C(OC)=C(C)C=3)N(C)[C@H]4[C@@H]21 PKVRCIRHQMSYJX-AIFWHQITSA-N 0.000 title abstract 6
- 229960000977 trabectedin Drugs 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- -1 ecteinascidin derivative compound Chemical class 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un compuesto derivado de ecteinascidina que tiene un sistema fusionado de cinco anillos de ecteinascidina con un puente 1,4 que tiene la estructura de formulas (1) o (2) y compuestos en los cuales el ûNH2 o el ûOH del puente 1,4 está derivatizado; con la excepcion de la ecteinascidina 583 o 597, y con la excepcion de los 14, 15 o 47 de la Patente de los EE.UU. No. 5721362. Preferiblemente, el sistema de cinco anillos de ecteinascidina tiene la formula (3) donde los anillos A y E son fenolicos, los anillos B y D son tetrahidro, y el anillo C es perhidro. Estos compuestos muestran actividad antitumoral. Composiciones farmacéuticas que contienen compuestos derivados de ecteinascidina. El uso de estos compuestos para la preparacion de un medicamento destinado al tratamiento de un tumor. Método de tratamiento de un tumor que comprende la administracion de una cantidad efectiva de un compuesto derivado de ecteinascidina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0009043A GB0009043D0 (en) | 2000-04-12 | 2000-04-12 | New autitumoural derivatives of ET-743 |
| PCT/GB2000/001852 WO2000069862A2 (en) | 1999-05-14 | 2000-05-15 | Hemisynthetic method and intermediates thereof |
| GB0022644A GB0022644D0 (en) | 2000-09-14 | 2000-09-14 | Antitumoral derivatives of ET-743 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032879A1 true AR032879A1 (es) | 2003-12-03 |
Family
ID=26244092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101773A AR032879A1 (es) | 2000-04-12 | 2001-04-16 | Compuestos derivados de ecteinascidina, sus composiciones farmaceuticas, sus usos y metodo de tratamiento de tumores |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7202361B2 (es) |
| EP (1) | EP1280809B1 (es) |
| JP (1) | JP5219323B2 (es) |
| KR (1) | KR100886496B1 (es) |
| CN (1) | CN1436191B (es) |
| AR (1) | AR032879A1 (es) |
| AT (1) | ATE299146T1 (es) |
| AU (1) | AU784249C (es) |
| BG (1) | BG65987B1 (es) |
| BR (1) | BRPI0110024B8 (es) |
| CA (1) | CA2406080C (es) |
| CZ (1) | CZ304749B6 (es) |
| DE (1) | DE60111845T2 (es) |
| DK (1) | DK1280809T3 (es) |
| EA (1) | EA006206B1 (es) |
| ES (1) | ES2244598T3 (es) |
| HK (1) | HK1049005B (es) |
| HU (1) | HU230918B1 (es) |
| IL (1) | IL152094A (es) |
| MX (1) | MXPA02010088A (es) |
| NO (1) | NO329125B1 (es) |
| NZ (1) | NZ521550A (es) |
| PL (1) | PL210703B1 (es) |
| PT (1) | PT1280809E (es) |
| SI (1) | SI1280809T1 (es) |
| SK (1) | SK288017B6 (es) |
| WO (1) | WO2001077115A1 (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ302168B6 (cs) * | 1998-05-11 | 2010-11-24 | Pharma Mar, S. A. | Metabolity ecteinascidinu 743 |
| MY164077A (en) | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
| AR035842A1 (es) | 1999-05-14 | 2004-07-21 | Pharma Mar Sa | Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo |
| US7919493B2 (en) | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
| US7420051B2 (en) * | 2000-05-15 | 2008-09-02 | Pharma Mar, S.A. | Synthetic process for the manufacture of an ecteinaschidin compound |
| MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
| GB0117402D0 (en) * | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
| GB0119243D0 (en) | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
| JP2005509650A (ja) * | 2001-10-19 | 2005-04-14 | ファルマ・マール・ソシエダード・アノニマ | 癌治療における抗腫瘍化合物の改良した使用 |
| JP4208469B2 (ja) * | 2002-01-29 | 2009-01-14 | 独立行政法人科学技術振興機構 | エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法 |
| GB0202544D0 (en) | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
| CA2544320A1 (en) | 2003-11-13 | 2005-06-02 | Pharma Mar, S.A.U. | Method of treating cancer using a combination comprising et-743 and 5-fluorouracil |
| JP2008514688A (ja) * | 2004-09-29 | 2008-05-08 | ファルマ・マル・エス・アー， ソシエダッド・ユニペルソナル | 抗炎症剤としてのエクテイナシジン化合物 |
| NZ554761A (en) | 2004-10-29 | 2010-01-29 | Pharma Mar Sa | Formulations comprising ecteinascidin and a disaccharide |
| WO2006083417A2 (en) * | 2004-12-20 | 2006-08-10 | The Trustees Of Columbia University In The City Of New York | Processes of making sesquiterpenoid tashironin, its analogs and their uses |
| US20090131498A1 (en) * | 2005-01-18 | 2009-05-21 | Danishefsky Samuel J | Enantioselective Synthesis of Merrilactone and Its Analogs |
| GB0522082D0 (en) | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
| WO2007087220A2 (en) * | 2006-01-25 | 2007-08-02 | The Trustees Of Columbia University In The City Of New York | The total synthesis of ecteinascidin 743 and derivatives thereof |
| FR2936951B1 (fr) * | 2008-10-10 | 2010-12-03 | Novexel | Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments |
| JP6037337B2 (ja) | 2010-05-25 | 2016-12-07 | ファルマ、マール、ソシエダード、アノニマＰｈａｒｍａ Ｍｒｓ，Ｓ．Ａ． | エクチナサイジン化合物の製造のための合成方法 |
| LT2786753T (lt) | 2010-11-12 | 2019-04-10 | Pharma Mar S.A. | Derinių terapija su antinavikiniu antibiotiku |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
| CN112679513B (zh) * | 2019-10-18 | 2023-08-25 | 南通诺泰生物医药技术有限公司 | 一种制备曲贝替定的关键中间体的方法 |
| AU2020388196B2 (en) | 2019-11-21 | 2025-08-14 | Pharma Mar, S.A. | Methods of treating small cell lung cancer with lurbinectedin formulations |
| CN114940682A (zh) * | 2022-05-18 | 2022-08-26 | 博瑞制药(苏州)有限公司 | 芦比替定的晶型及其制备方法和用途 |
| CN115677728A (zh) * | 2022-11-02 | 2023-02-03 | 成都科岭源医药技术有限公司 | 一种海鞘素类化合物中间体的制备方法 |
| EP4651871A2 (en) * | 2023-01-17 | 2025-11-26 | Adcytherix SAS | Ecteinascidin derivative antibody drug conjugates |
| WO2025077996A1 (en) | 2023-10-09 | 2025-04-17 | Pharma Mar, S.A. | Synthetic process for the manufacture of ecteinascidin compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59225189A (ja) | 1983-06-03 | 1984-12-18 | Shionogi & Co Ltd | キノナミン誘導体およびその製造法 |
| JPS6084288A (ja) | 1983-10-13 | 1985-05-13 | Shionogi & Co Ltd | シアノキノナミンアセテ−ト類およびその製造法 |
| US5089273A (en) * | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
| WO1987007610A2 (en) | 1986-06-09 | 1987-12-17 | University Of Illinois | Ecteinascidins 729, 743, 745, 759a, 759b and 770 |
| US5149804A (en) * | 1990-11-30 | 1992-09-22 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins 736 and 722 |
| US5256663A (en) * | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
| US5721365A (en) * | 1989-09-15 | 1998-02-24 | Us Health | N-substituted piperazine NONOates |
| US5478932A (en) * | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
| US5721362A (en) | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
| US5985876A (en) * | 1997-04-15 | 1999-11-16 | Univ Illinois | Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| CZ302168B6 (cs) | 1998-05-11 | 2010-11-24 | Pharma Mar, S. A. | Metabolity ecteinascidinu 743 |
| US6124292A (en) | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
| AR035842A1 (es) | 1999-05-14 | 2004-07-21 | Pharma Mar Sa | Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo |
| WO2001053299A1 (en) * | 2000-01-19 | 2001-07-26 | The Trustees Of Columbia University In The City Of New York | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
-
2001
- 2001-04-12 AU AU46729/01A patent/AU784249C/en not_active Expired
- 2001-04-12 CN CN01810939XA patent/CN1436191B/zh not_active Expired - Lifetime
- 2001-04-12 US US10/240,963 patent/US7202361B2/en not_active Expired - Lifetime
- 2001-04-12 DE DE60111845T patent/DE60111845T2/de not_active Expired - Lifetime
- 2001-04-12 NZ NZ521550A patent/NZ521550A/en not_active IP Right Cessation
- 2001-04-12 PL PL357574A patent/PL210703B1/pl unknown
- 2001-04-12 PT PT01919669T patent/PT1280809E/pt unknown
- 2001-04-12 IL IL152094A patent/IL152094A/en active IP Right Grant
- 2001-04-12 JP JP2001575588A patent/JP5219323B2/ja not_active Expired - Lifetime
- 2001-04-12 ES ES01919669T patent/ES2244598T3/es not_active Expired - Lifetime
- 2001-04-12 HK HK03101292.0A patent/HK1049005B/en not_active IP Right Cessation
- 2001-04-12 WO PCT/GB2001/001667 patent/WO2001077115A1/en not_active Ceased
- 2001-04-12 CZ CZ2002-3352A patent/CZ304749B6/cs not_active IP Right Cessation
- 2001-04-12 HU HUP0300534A patent/HU230918B1/hu unknown
- 2001-04-12 DK DK01919669T patent/DK1280809T3/da active
- 2001-04-12 EA EA200201083A patent/EA006206B1/ru not_active IP Right Cessation
- 2001-04-12 CA CA2406080A patent/CA2406080C/en not_active Expired - Lifetime
- 2001-04-12 SI SI200130394T patent/SI1280809T1/sl unknown
- 2001-04-12 KR KR1020027013749A patent/KR100886496B1/ko not_active Expired - Lifetime
- 2001-04-12 BR BRPI0110024-6 patent/BRPI0110024B8/pt not_active IP Right Cessation
- 2001-04-12 EP EP01919669A patent/EP1280809B1/en not_active Expired - Lifetime
- 2001-04-12 AT AT01919669T patent/ATE299146T1/de active
- 2001-04-12 MX MXPA02010088A patent/MXPA02010088A/es active IP Right Grant
- 2001-04-12 SK SK1435-2002A patent/SK288017B6/sk not_active IP Right Cessation
- 2001-04-16 AR ARP010101773A patent/AR032879A1/es active IP Right Grant
-
2002
- 2002-10-11 NO NO20024906A patent/NO329125B1/no not_active IP Right Cessation
- 2002-10-24 BG BG107220A patent/BG65987B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032879A1 (es) | Compuestos derivados de ecteinascidina, sus composiciones farmaceuticas, sus usos y metodo de tratamiento de tumores | |
| MX9704777A (es) | Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen. | |
| ES2175127T3 (es) | Derivados de la quinazolina y su uso. | |
| MX9308016A (es) | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. | |
| SE8602723L (sv) | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem | |
| GT199800046A (es) | Compuestos de pirazina. | |
| AR002705A1 (es) | Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen. | |
| UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
| AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
| ES2037752T3 (es) | Utilizacion de un derivado de benzoxazol y su procedimiento de preparacion. | |
| DK1365808T3 (da) | Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 | |
| BR9813651A (pt) | Compostos antipicornavirais e métodos para o seu uso e preparação | |
| CO5011053A1 (es) | Procedimiento para la produccion de una forma de dosificacion solida que contiene carvedilol e hidroclorotiazida y formas farmaceuticas obtenidas por dicho procedimiento | |
| ECSP034766A (es) | Una combinacion que comprende combretastatina y agentes anticancerigenos | |
| AR030039A1 (es) | Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento | |
| AR030540A1 (es) | Compuestos antipicornavirales y composiciones, su uso farmaceutico, y materiales para su sintesis | |
| MX163574B (es) | Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido | |
| MX9308025A (es) | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. | |
| UY29869A1 (es) | Compuestos de benzamida | |
| ES2046193T3 (es) | Un procedimiento para la preparacion de un compuesto de imidazolidinona. | |
| MX16046A (es) | Procedimiento para la preparacion de 2-amino-1,2,3,4-tetrahidronaftalenos substituidos en el anillo,compuesto obtenido y composicion farmaceutica que lo incluye | |
| ES2123499T3 (es) | Metodos y composiciones para tratamiento de infecciones virales. | |
| ES2171459T3 (es) | Polvo para administracion nasal de farmaco peptidico o proteinaceo. | |
| ECSP034530A (es) | Derivados de 6-metil-tramadol sustituido en o | |
| MX9306529A (es) | Derivados de pirazol condensado, metodo para fabricarlos y composicion farmaceutica que los contiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |